Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

208 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Radical Resection in Entero-Pancreatic Neuroendocrine Tumors: Recurrence-Free Survival Rate and Definition of a Risk Score for Recurrence.
Merola E, Pascher A, Rinke A, Bartsch DK, Zerbi A, Nappo G, Carnaghi C, Ciola M, McNamara MG, Zandee W, Bertani E, Marcucci S, Modica R, Grützmann R, Fazio N, de Herder W, Valle JW, Gress TM, Fave GD, de Pretis G, Perren A, Wiedenmann B, Pavel ME. Merola E, et al. Among authors: pavel me. Ann Surg Oncol. 2022 Sep;29(9):5568-5577. doi: 10.1245/s10434-022-11837-1. Epub 2022 May 18. Ann Surg Oncol. 2022. PMID: 35583694
Octreotide versus octreotide plus interferon-alpha in endocrine gastroenteropancreatic tumors: a randomized trial.
Arnold R, Rinke A, Klose KJ, Müller HH, Wied M, Zamzow K, Schmidt C, Schade-Brittinger C, Barth P, Moll R, Koller M, Unterhalt M, Hiddemann W, Schmidt-Lauber M, Pavel M, Arnold CN. Arnold R, et al. Clin Gastroenterol Hepatol. 2005 Aug;3(8):761-71. doi: 10.1016/s1542-3565(05)00481-7. Clin Gastroenterol Hepatol. 2005. PMID: 16234004 Clinical Trial.
Somatostatin-producing neuroendocrine tumors of the duodenum and pancreas: incidence, types, biological behavior, association with inherited syndromes, and functional activity.
Garbrecht N, Anlauf M, Schmitt A, Henopp T, Sipos B, Raffel A, Eisenberger CF, Knoefel WT, Pavel M, Fottner C, Musholt TJ, Rinke A, Arnold R, Berndt U, Plöckinger U, Wiedenmann B, Moch H, Heitz PU, Komminoth P, Perren A, Klöppel G. Garbrecht N, et al. Endocr Relat Cancer. 2008 Mar;15(1):229-41. doi: 10.1677/ERC-07-0157. Endocr Relat Cancer. 2008. PMID: 18310290
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification.
Klöppel G, Couvelard A, Perren A, Komminoth P, McNicol AM, Nilsson O, Scarpa A, Scoazec JY, Wiedenmann B, Papotti M, Rindi G, Plöckinger U; Mallorca Consensus Conference participants; European Neuroendocrine Tumor Society. Klöppel G, et al. Neuroendocrinology. 2009;90(2):162-6. doi: 10.1159/000182196. Epub 2009 Aug 28. Neuroendocrinology. 2009. PMID: 19060454 Free article. No abstract available.
Angiopoietin-2 promotes disease progression of neuroendocrine tumors.
Detjen KM, Rieke S, Deters A, Schulz P, Rexin A, Vollmer S, Hauff P, Wiedenmann B, Pavel M, Scholz A. Detjen KM, et al. Clin Cancer Res. 2010 Jan 15;16(2):420-9. doi: 10.1158/1078-0432.CCR-09-1924. Epub 2010 Jan 12. Clin Cancer Res. 2010. PMID: 20068079
ENETS consensus guidelines for the management of brain, cardiac and ovarian metastases from neuroendocrine tumors.
Pavel M, Grossman A, Arnold R, Perren A, Kaltsas G, Steinmüller T, de Herder W, Nikou G, Plöckinger U, Lopes JM, Sasano H, Buscombe J, Lind P, O'Toole D, Oberg K; Palma de Mallorca Consensus Conference Participants. Pavel M, et al. Neuroendocrinology. 2010;91(4):326-32. doi: 10.1159/000287277. Epub 2010 May 6. Neuroendocrinology. 2010. PMID: 20453466 Free article. No abstract available.
208 results